Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma.
Kisseberth
W C
WC
Department of Medical Sciences, School of Veterinary Medicine, University of Wisconsin, Madison 53706, USA.
MacEwen
E G
EG
Helfand
S C
SC
Vail
D M
DM
London
C L
CL
Keller
E
E
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004317:Doxorubicin / Q000008:administration & dosage*; D004337:Drug Carriers; D005260:Female; D008081:Liposomes; D009101:Multiple Myeloma / Q000188:drug therapy / Q000662:veterinary*; D012074:Remission Induction
D000903:Antibiotics, Antineoplastic; D004337:Drug Carriers; D008081:Liposomes; D004317:Doxorubicin